• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者根据症状严重程度被分配到慢性阻塞性肺疾病全球倡议(GOLD)组别的差异。

Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.

作者信息

Moya-Álvarez Virginia, Quevedo-Marín Juan Luis, Ji Zichen, Navarro-Jiménez Cristina, Jiménez-García Rodrigo, López-de-Andrés Ana, Pérez-Trullén Alfonso, de Miguel-Díez Javier

机构信息

Faculty of Medicine, Francisco de Vitoria University, Madrid 28223, Spain.

Rey Juan Carlos University, Madrid 28922, Spain.

出版信息

Int J Chron Obstruct Pulmon Dis. 2020 Aug 12;15:1987-1995. doi: 10.2147/COPD.S253445. eCollection 2020.

DOI:10.2147/COPD.S253445
PMID:32848383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7430767/
Abstract

INTRODUCTION

The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) taking into account the symptoms. The modified Medical Research Council's dyspnea scale (mMRC) and the COPD assessment test (CAT) are used to assess these symptoms. In this study, we analyze the concordance of GOLD classification using mMRC and CAT.

PATIENTS AND METHODS

This is an observational study of a cohort of 169 patients with COPD, who were classified following the GOLD 2017 recommendations, using both mMRC and CAT. A concordance analysis was applied, and a ROC curve was generated to identify the CAT score that best concorded with the mMRC scale.

RESULTS

The concordance for the GOLD groups classified by CAT and mMRC was moderate ( 0.492). For mMRC score of 1 and 2, a CAT score of ≥9 and ≥16 showed the maximum value of the Youden index, respectively. By reclassifying the patients with the new cut-off points obtained, the best concordance was obtained between the cut-off point for CAT of 16 and for mMRC of 2, followed by CAT of 9 and mMRC of 1.

CONCLUSION

Because of the deficient concordance between CAT and mMRC, we propose the use of new cut-off points in future updates of the GOLD strategy.

摘要

引言

全球肺部疾病组织(GOLD)根据症状对慢性阻塞性肺疾病(COPD)患者进行分类。改良的医学研究委员会呼吸困难量表(mMRC)和慢性阻塞性肺疾病评估测试(CAT)用于评估这些症状。在本研究中,我们分析了使用mMRC和CAT进行GOLD分类的一致性。

患者与方法

这是一项对169例COPD患者队列的观察性研究,这些患者按照GOLD 2017推荐标准,使用mMRC和CAT进行分类。应用一致性分析,并生成ROC曲线以确定与mMRC量表最一致的CAT评分。

结果

CAT和mMRC对GOLD组的分类一致性为中等(0.492)。对于mMRC评分为1和2的情况,CAT评分≥9和≥16分别显示约登指数的最大值。通过使用获得的新切点对患者重新分类,在CAT为16和mMRC为2的切点之间获得了最佳一致性,其次是CAT为9和mMRC为1。

结论

由于CAT和mMRC之间的一致性不足,我们建议在GOLD策略的未来更新中使用新的切点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/2f569c61719a/COPD-15-1987-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/90a5346495d1/COPD-15-1987-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/85969aea2ceb/COPD-15-1987-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/3a410b85fc58/COPD-15-1987-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/79c298a143d3/COPD-15-1987-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/2f569c61719a/COPD-15-1987-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/90a5346495d1/COPD-15-1987-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/85969aea2ceb/COPD-15-1987-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/3a410b85fc58/COPD-15-1987-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/79c298a143d3/COPD-15-1987-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763a/7430767/2f569c61719a/COPD-15-1987-g0005.jpg

相似文献

1
Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.慢性阻塞性肺疾病(COPD)患者根据症状严重程度被分配到慢性阻塞性肺疾病全球倡议(GOLD)组别的差异。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 12;15:1987-1995. doi: 10.2147/COPD.S253445. eCollection 2020.
2
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
3
Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.使用 COPD 评估测试 (CAT) 或改良版医学研究理事会呼吸困难评分 (mMRC) 对 COPD 组进行分类的差异:一项横断面分析。
BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.
4
Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study.呼吸症状(COPD 评估测试和改良的医学研究委员会呼吸困难评分)和 GOLD-ABCD COPD 分类:LASSYC 研究。
J Bras Pneumol. 2021 Nov 12;47(5):e20210156. doi: 10.36416/1806-3756/e20210156. eCollection 2021.
5
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.
6
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.COPD 评估测试(CAT)与改良版医学研究理事会呼吸困难量表(mMRC)在 COPD 患者临床症状、合并症及医疗资源利用评估方面的比较。
J Formos Med Assoc. 2019 Jan;118(1 Pt 3):429-435. doi: 10.1016/j.jfma.2018.06.018. Epub 2018 Aug 25.
7
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.改良医学研究委员会呼吸困难量表、慢性阻塞性肺疾病评估测试及临床慢性阻塞性肺疾病问卷在慢性阻塞性肺疾病新全球倡议分期及死亡率中对症状评估的差异效应
Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.
8
GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.慢性阻塞性肺疾病的GOLD分类:症状与急性加重风险评估标准中的不一致性
COPD. 2017 Feb;14(1):1-6. doi: 10.1080/15412555.2016.1230844. Epub 2016 Oct 10.
9
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病(COPD)全球倡议(GOLD)分期系统应用于美国基层医疗队列,并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
10
Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.慢性阻塞性肺疾病全球倡议(GOLD)分类中改良的医学研究理事会呼吸困难量表能更好地反映日常生活中的身体活动情况。
Respir Care. 2018 Jan;63(1):77-85. doi: 10.4187/respcare.05636. Epub 2017 Sep 5.

引用本文的文献

1
GOLD COPD Exacerbation History Categories and Disease Outcomes.慢性阻塞性肺疾病全球倡议(GOLD)的急性加重病史分类与疾病转归
JAMA Netw Open. 2024 Dec 2;7(12):e2445488. doi: 10.1001/jamanetworkopen.2024.45488.
2
The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.慢性阻塞性肺疾病在实际临床实践中健康状况、呼吸道症状和呼吸困难的概念独立性
Diagnostics (Basel). 2023 Jul 27;13(15):2492. doi: 10.3390/diagnostics13152492.

本文引用的文献

1
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.重新定义 18577 例慢性阻塞性肺疾病患者中全球慢性阻塞性肺病倡议分类高症状负担的切点。
J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003.
2
Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.以圣乔治呼吸问卷评分25(及20)为参照,根据慢性阻塞性肺疾病全球倡议(GOLD)标准,研究临床慢性阻塞性肺疾病问卷、慢性阻塞性肺疾病评估测试及改良医学研究委员会量表的敏感性、特异性和曲线下面积。
Int J Chron Obstruct Pulmon Dis. 2016 May 18;11:1045-52. doi: 10.2147/COPD.S99793. eCollection 2016.
3
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.肺功能正常的吸烟者症状的临床意义
N Engl J Med. 2016 May 12;374(19):1811-21. doi: 10.1056/NEJMoa1505971.
4
Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.比较 CAT 与 mMRC 对 COPD 患者特征的影响:一项回顾性、横断面研究。
NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.
5
Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.慢性阻塞性肺疾病(COPD)患者中与改良医学研究委员会分级相对应的COPD评估测试分数。
Korean J Intern Med. 2015 Sep;30(5):629-37. doi: 10.3904/kjim.2015.30.5.629. Epub 2015 Aug 27.
6
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
7
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.慢性阻塞性肺疾病病死率预测比较 GOLD 2007 及 2011 分期系统:一项个体患者资料的汇总分析。
Lancet Respir Med. 2015 Jun;3(6):443-50. doi: 10.1016/S2213-2600(15)00157-5. Epub 2015 May 17.
8
Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.2013年慢性阻塞性肺疾病全球倡议(GOLD)分级能否提高预测肺功能下降、急性加重和死亡率的能力:对为期4年的UPLIFT试验的事后分析
BMC Pulm Med. 2014 Oct 18;14:163. doi: 10.1186/1471-2466-14-163.
9
The COPD assessment test: a systematic review.慢性阻塞性肺疾病评估测试:系统评价。
Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214. Epub 2014 Jul 3.
10
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.